Modeling the effects of vaccination on rotavirus infection
 Onyango Lawrence Omondi^{1, 2}Email author,
 Chuncheng Wang^{1},
 Xiaoping Xue^{1} and
 Owuor George Lawi^{3}
https://doi.org/10.1186/s1366201507221
© Omondi et al. 2015
Received: 27 September 2015
Accepted: 8 December 2015
Published: 18 December 2015
Abstract
In this article, a mathematical model of a rotavirus infection incorporating vaccination has been developed and comprehensively analyzed. The basic reproduction number, \(R_{v}\), has been established. Proof of existence of a positive endemic equilibrium has been derived. Through the analysis and simulation, it has been shown that both diseasefree and endemic equilibria are globally asymptotically stable provided that \(R_{v}<1\) and \(R_{v}>1\), respectively. Real data has been fitted to the model, showing that it can be used to predict the nature of a rotavirus infection in a population. The results of both the analysis and the simulation show that vaccination is a very effective way of controlling rotavirus infection.
Keywords
1 Introduction
Rotavirus is a pathogen of the gastrointestinal tract that causes acute gastroenteritis and diarrhea in infants and young children of below five years of age worldwide [1, 2]. In fact, 95% of children worldwide are infected by the time they reach age 5 with peak incidence occurring between ages of four months and 36 months [3]. It gets its name from the fact that, under a microscope, the virus resembles a wheel. Severe rotavirus infections occur most commonly in infants and children below six to 24 months of age. Its symptoms, which may last for eight days, include; fever, nausea, vomiting, abdominal cramps, and frequent watery diarrhea [4–6]. There are seven species of rotavirus, referred to as A, B, C, D, E, F, and G. Humans are primarily infected by species A, B, and C, most commonly by A. The diagnosis of a rotavirus infection is commonly made clinically, although a rapid antigen stool test is available. Rotavirus is primarily transmitted by the faecaloral route, via contact with contaminated hands, surfaces and objects, and possibly by the respiratory route [7–9]. For further information on diseases with multiple routes of infection, see [10, 11]. The incubation period is about two days [12, 13]. Reinfection does occur; however, with each infection, immunity develops, so subsequent infections are less severe [14]. Indeed, it has been observed in [15] that children who experienced two natural rotavirus infection had complete protection against moderatetosevere diarrhea compared to children without a previous infection. It has also been established that both symptomatic and asymptomatic infections confer a similar degree of protection [15].
It is estimated that about 90% of children worldwide will have experienced a rotavirus infection by age five [16] with an annual mortality in excess of \(600\mbox{,}000\) among children [17, 18]. Rotavirusrelated hospitalizations can account for as many as 2.5% of all hospitalizations of children. Some review analyses show that rotavirus accounted for 6% of diarrhea episodes and 20% of deaths caused by diarrhea in children less than five years of age in developing countries [19]. In a study carried out in Ghana, it was observed that 11.8% of the 243 children examined were coinfected with plasmodium falciparum and enteropathogens, where rotavirus was also found to be one of the enteropathogens common in more than half of the patients [20]. In Kenya, rotavirus causes more than \(7\mbox{,}500\) deaths yearly. The results of a study of rotavirus infections among HIVinfected children in Nairobi, Kenya, indicate that rotavirus is an important viral etiological agent causing diarrhea in HIV  seropositive children [21].
The incidence of the rotavirus infection has been observed to be similar in both industrialized and developing countries, suggesting that adequate control measures may not be achieved by improvements in water supply, hygiene or sanitation. Consequently, development, trial, and widespread use of rotavirus vaccines are recommended to prevent both severe and fatal rotavirus disease [19]. So far, no specific cure for rotavirus infection has been discovered. Therefore disease control primarily involves preventing dehydration. Recent compelling data on the disease burden of rotavirus and the power of vaccines to prevent it in lowresource settings informed the WHO’s June 2009 recommendation that rotavirus vaccination be included in every nation’s immunizations program [22].
In this work, we have developed a new mathematical model for rotavirus infection that incorporates vaccination. We have analyzed it comprehensively and proved that a positive endemic equilibrium \(E^{*}(S^{*}, V^{*}, I^{*})\) exists and is globally stable. In addition, we have performed numerical simulations to confirm and demonstrate the validity of the various assumptions and conclusions made during the analysis. The paper is organized as follows. In this section, we have provided background information as regards rotavirus infection; in Section 2, we developed the model; Section 3 established a diseasefree equilibrium and derived the basic reproduction number, \(R_{v}\). We have also proved the existence of a positive endemic equilibrium in this section and finally proved that the diseasefree equilibrium is globally asymptotically stable. In Section 4, we proved that the endemic equilibrium is globally asymptotically stable; numerical simulation is performed in Section 5. Finally, a discussion and conclusion is presented in Section 6.
2 Model formulation and description
The total human population size, N, at any time is subdivided into classes: susceptible S, infectious with rotavirus I, vaccinated V and removed R. Since the incubation period is very short, we assume that the probability of survival till the infectious state for the individuals exposed to rotavirus is unity and therefore exclude the exposure stage. The individuals infected with rotavirus include both symptomatic and asymptomatic cases [18]. The removed class comprises those who have been removed from the scene of infection by such means as infectionacquired immunity [15] and death. Although it is possible to have some level of immunity to rotavirus from maternal antibodies due to breastfeeding [23], we explore the effect of vaccination at birth and vaccination of susceptibles. The human population is not assumed to be constant, since birth, migration, emigration, and death occur. The recruitment into susceptible population takes place at the rate of \((1\rho)\Lambda\), while recruitment into the vaccinated class occurs at the rate of ρΛ. Susceptibles are subsequently vaccinated at the rate γ, while the vaccine efficacy wanes at the rate of ω. The parameter \(0 < \epsilon< 1\) models the expected decrease in the risk of infection as a result of vaccination. Disease mortality is assumed to take place at the rate τ, while the rate of flow into the removed class is taken as κ. Let μ define the per capita natural death rate. We assume that the massaction incidence transmission is defined by \(\beta SI\) where β is the effective contact rate for disease transmission.
3 Equilibrium points of the model
3.1 The basic reproduction number \(R_{v}\)
We now establish the existence of an endemic equilibrium. This is done in the lemma below.
3.2 Existence of a unique positive endemic equilibrium \(E^{*}(S^{*}, V^{*}, I^{*})\)
Lemma 1
An endemic equilibrium \(E^{*}(S^{*}, V^{*},I^{*})\) exists provided that \(R_{v} >1\).
Proof
3.3 Global stability of the diseasefree equilibrium
The global stability of the diseaseequilibrium \(E^{0}\) is easily proved by using a common quadratic Lyapunov function and LaSalle’s invariance principle.
Theorem 2
If \(R_{v} \leq0\), then the diseasefree equilibrium of (3) is globally asymptotically stable in Ω.
Proof
If \(L'=0\), then \(I=0\) or \(R_{v}=0\). Hence L is a Lyapunov function on Ω. Thus \(I \rightarrow0\) as \(t \rightarrow\infty\). When we substitute \(I=0\) in (3), we obtain \(S+V\rightarrow\frac {\Lambda}{\mu}\). Therefore it follows from LaSalle’s invariance principle [30–32] that every solution of (3), with initial conditions in Ω, approaches \(E^{0}\) as \(t\rightarrow\infty\). □
4 Global stability of the endemic equilibrium of the model
To prove the global stability of the endemic equilibrium, we use the Lyapunov direct method. We construct the Lyapunov function by using the logarithmic functions.
Theorem 3
If \(R_{v} > 1\) then the unique endemic equilibrium \(E^{*}(S^{*}, V^{*}, I^{*})\) of (3) is globally asymptotically stable in the interior of Ω.
Proof
Thus, using the arithmeticgeometric mean inequality, \(L'\leq0\) with equality if \(S=S^{*}\), \(V=V^{*}\), and \(I=I^{*}\). This implies that the largest compact invariant set in \(\{(S, V, I)\in\Omega:L'=0\}\) is the singleton \(\{E^{*}\}\), where \(E^{*}\) is the endemic equilibrium. Therefore, LaSalle’s invariance principle [30–32] implies that \(E^{*}\) is globally asymptotically stable in the interior of Ω. □
5 Numerical simulations
Parameter  Symbol  Value  Source 

Recruitment rate of humans  Λ  \(4.109\times10^{3}~\text{people/day}\)  [33] 
Recruitment rate of vaccinated individuals  ρ  \(1.884\times 10^{3}~\text{people/day}\)  [34] 
Natural death rate of humans  μ  \(2.537\times10^{5}~\text{day}^{1}\)  [33] 
Rotavirusinduced deaths  τ  \(4.466\times10^{5}~\text{day}^{1}\)  [19] 
Effective contact rate  β  \(\text{Variable}~\text{day}^{1}\)  Variable 
Rate of flow into the removed class  κ  \(9.5\times 10^{4}~\text{day}^{1}\)  Estimated 
Expected decrease in the risk of infection  ϵ  \(1.0\times 10^{3}~\text{day}^{1}\)  Assumed 
Vaccine efficacy waning rate  ω  \(2.778\times10^{3}~\text{day}^{1}\)  [35] 
Vaccination rate  γ  \(1.884\times10^{3}~\text{day}^{1}\)  [34] 
Number of children (<5 years of age) who are infected with rotavirus in Kenya between January 2013 to July 2015
Period  JanuaryMarch  AprilJune  JulySeptember  OctoberDecember 

2013  116,672  96,619  71,097  78,389 
2014  94,796  85,681  63,805  80,212 
2015  82,035  60,159     
6 Discussion and conclusion
From the numerical simulation results, Figure 1(a) shows that the diseasefree equilibrium is globally asymptotically stable when \(R_{v}=0.9692\), which is less than unity. In the figure, we also note that there are few individuals who are vaccinated compared to those who are susceptible. This may be due to the fact that vaccination is not necessary at this time since there are still no infections in the population; that is, \(I=0\). Figure 1(b) shows that the endemic equilibrium is globally asymptotically stable for \(R_{v}=1.7195\). The figure also depicts an increase in the number of infected individuals at the onset of an infection before the global asymptotic stability is attained. Therefore it is highly recommended that immediate control measures be undertaken whenever there is an outbreak of a rotavirus infection. This will help in preventing a possible outbreak of an epidemic. This increase is also attributed to the fact that the rotavirus is a highly contagious virus that infects nearly all children by their fifth birthday. The figure also shows that the disease is persistent in the population; hence longterm control measures like vaccination, maintaining hygiene, and safe drinking water are recommended.
Figure 2 shows how varying ϵ affects both the susceptible and the vaccinated individuals. Figure 2(a) is plotted with \(\epsilon=0.01\) and \(R_{v}=1.6135\). In this figure, we observe that there are more susceptible individuals than vaccinated ones. Since ϵ is the expected decrease in the risk of infection as a result of vaccination, this variation may be a result of weak vaccines. The number of infections is likely to be high in this case because there are many susceptibles. When \(\epsilon=0.001\), \(R_{v}\) reduces to 1.2163 and the number of vaccinated individuals are now more than the susceptibles as evident in Figure 2(b), consequently resulting in few infectives. This therefore is an indication that stronger vaccines can significantly reduce rotavirus infections in a population. A very low value of ϵ indicates that the vaccine is very effective. It can therefore be concluded that vaccination at birth helps in reducing the number of infectives in a population. The effects of vaccination have been shown to be positive in areas where prevalence is high. These findings strongly support the search for and developments of effective vaccines by the WHO [9, 18, 36–38].

Lack of elaborate data because most hospitals in Kenya, especially in rural areas, started rotavirus vaccination in 2013. This is why our plot also started from the same year.

Not all cases of rotavirus infections are reported to the hospitals, and also not all births are carried out in hospitals. This results in inaccurate reports on the state of rotavirus infections in the country.

There is a delay in sending data from the subdistrict hospitals to the Ministry headquarters. In the process, a lot of data and information get lost.

Most people in rural parts of Kenya are not following the vaccination schedules. This leads to false reports on the effectiveness of the vaccines.

Finally, the model has massaction transmission, which assumes homogeneous mixing. However, in reality, people do not mix homogeneously and that may result in disease clustering and persistence.
In summary, a mathematical model that shows the effects of vaccination on rotavirus infection has been developed and analyzed. The basic reproduction number (\(R_{v}\)) has been established. It has been shown that an endemic equilibrium exists provided that \(R_{v}>1\). Additionally, it has been proved that both the diseasefree and the endemic equilibria are globally asymptotically stable. Numerical simulations have been performed using data attained from Ministry of Health, Kenya, to support the analysis and to show the effectiveness of vaccination as a way of controlling rotavirus infection. Real data has been fitted into the model to prove that it can be used to predict the rate of rotavirus infection in a population. From this work, it is recommended that all newborns be vaccinated (if possible) in order to effectively control rotavirus infection. For future work, we suggest that an investigation of how inclusion of seasonality will affect this model should be done. We also propose that future researchers should try and implement this model in a multigroup framework with heterogeneous contacts. For further details see the work by Wang and Cao [39].
Declarations
Acknowledgements
The authors of this work are very grateful to the Ministry of Health (Kenya) for allowing us to access and use their data. We are also very grateful to the Journal editors and the anonymous reviewers for their comments and recommendations, which have greatly improved our manuscript and make it more suitable for readers of the journal. Finally, we would like to appreciate the assistance given to us by the employees we dealt with at the Ministry.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Authors’ Affiliations
References
 White, LJ, Buttery, J, Cooper, B, Nokes, DJ, Medley, G: Rotavirus within day care centres in Oxfordshire, UK: characterization of partial immunity. J. R. Soc. Interface 5, 14811490 (2008) View ArticleGoogle Scholar
 Rotavirus Fact Sheet. Department of Health and Human Services, Centers for Disease Control and Prevention (2004) Google Scholar
 Shim, E, Banks, H, CastilloChavez, C: Seasonality of rotavirus infection with its vaccination. Contemp. Math. 410, 327347 (2006) View ArticleMathSciNetGoogle Scholar
 Anderson, EJ, Weber, SG: Rotavirus infection in adults. Lancet Infect. Dis. 4, 9199 (2004) View ArticleGoogle Scholar
 Ruuska, T, Vesikari, T: Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand. J. Infect. Dis. 22, 259267 (1990) View ArticleGoogle Scholar
 McNeal, MM, Bernstein, DI: Rotaviruses. In: Viral Infections of Humans, pp. 713732. Springer, Berlin (2014) Google Scholar
 Dennehy, PH: Transmission of rotavirus and other enteric pathogens in the home. Pediatr. Infect. Dis. J. 19(10), S103S105 (2000) View ArticleGoogle Scholar
 Nitiema, LW, Nordgren, J, Ouermi, D, Dianou, D, Traore, AS, Svensson, L, Simpore, J: Burden of rotavirus and other enteropathogens among children with diarrhea in Burkina Faso. Int. J. Infect. Dis. 15(9), e646e652 (2011) View ArticleGoogle Scholar
 Snelling, T, Markey, P, Carapetis, J, Andrews, R: Rotavirus infection in Northern Territory before and after vaccination. Microbiol. Aust. 33(2), 6163 (2012) Google Scholar
 Wang, Y, Jin, Z, Yang, Z, Zhang, ZK, Zhou, T, Sun, GQ: Global analysis of an SIS model with an infective vector on complex networks. Nonlinear Anal., Real World Appl. 13(2), 543557 (2012) MATHView ArticleMathSciNetGoogle Scholar
 Wang, Y, Jin, Z: Global analysis of multiple routes of disease transmission on heterogeneous networks. Phys. A, Stat. Mech. Appl. 392(18), 38693880 (2013) View ArticleMathSciNetGoogle Scholar
 Hochwald, C, Kivela, L: Rotavirus vaccine, live, oral, tetravalent (RotaShield). Pediatr. Nursing 25(2), 203204 (1998) Google Scholar
 Jain, P, Jain, A: Waterborne viral gastroenteritis: an introduction to common agents. In: Water and Health, pp. 5374. Springer, Berlin (2014) View ArticleGoogle Scholar
 Linhares, A, Gabbay, Y, Mascarenhas, J, Freitas, R, Flewett, T, Beards, G: Epidemiology of rotavirus subgroups and serotypes in Belem, Brazil: a threeyear study. Ann. Inst. Pasteur Virol. 139 8899 (1988) View ArticleGoogle Scholar
 Velázquez, FR, Matson, DO, Calva, JJ, Guerrero, ML, Morrow, AL, CarterCampbell, S, Glass, RI, Estes, MK, Pickering, LK, RuizPalacios, GM: Rotavirus infection in infants as protection against subsequent infections. N. Engl. J. Med. 335(14), 10221028 (1996) View ArticleGoogle Scholar
 Parashar, UD, Bresee, JS, Gentsch, JR, Glass, RI: Rotavirus. Emerg. Infect. Dis. 4(4), 561570 (1998) View ArticleGoogle Scholar
 Dennehy, PH: Rotavirus infection: a disease of the past? Infect. Dis. Clin. North Am. 29(4), 617635 (2015) View ArticleGoogle Scholar
 Parez, N: Rotavirus gastroenteritis: why to back up the development of new vaccines? Comp. Immunol. Microbiol. Infect. Dis. 31(2), 253269 (2008) View ArticleGoogle Scholar
 Parashar, UD, Hummelman, EG, Bresee, JS, Miller, MA, Glass, RI: Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9(5), 565572 (2003) View ArticleGoogle Scholar
 Reither, K, Ignatius, R, Weitzel, T, SeiduKorkor, A, Anyidoho, L, Saad, E, DjieMaletz, A, Ziniel, P, AmooSakyi, F, Danikuu, F, Danour, S, Otchwemah, RN, Schreier, E, Bienzle, U, Stark, K, Mockenhaupt, FP: Acute childhood diarrhoea in northern Ghana: epidemiological, clinical and microbiological characteristics. BMC Infect. Dis. 7, 104 (2007) View ArticleGoogle Scholar
 Kiulia, NM, Nyaundi, JK, Peenze, I, Nyachieo, A, Musoke, RN, Steele, AD, Mwenda, JM: Rotavirus infections among HIVinfected children in Nairobi, Kenya. J. Trop. Pediatr. 55(5), 318323 (2009) View ArticleGoogle Scholar
 Wardlaw, T, Salama, P, Brocklehurst, C, Chopra, M, Mason, E: Diarrhoea: why children are still dying and what can be done. Lancet 375(9718), 870872 (2010) View ArticleGoogle Scholar
 Bishop, RF, Davidson, G, Holmes, I, Ruck, B: Virus particles in epithelial cells of duodenal mucosa from children with acute nonbacterial gastroenteritis. Lancet 302(7841), 12811283 (1973) View ArticleGoogle Scholar
 Heffernan, J, Smith, R, Wahl, L: Perspectives on the basic reproductive ratio. J. R. Soc. Interface 2(4), 281293 (2005) View ArticleGoogle Scholar
 Diekmann, O, Heesterbeek, J, Metz, JA: On the definition and the computation of the basic reproduction ratio \(R_{0}\) in models for infectious diseases in heterogeneous populations. J. Math. Biol. 28(4), 365382 (1990) MATHView ArticleMathSciNetGoogle Scholar
 van den Driessche, P, Watmough, J: Reproduction numbers and subthreshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180, 2948 (2002) MATHView ArticleMathSciNetGoogle Scholar
 Li, J, Blakeley, D, Smith, RJ: The failure of R0. Comput. Math. Methods Med. 2011, 527610 (2011) View ArticleMathSciNetGoogle Scholar
 Eigenwillig, A: Real root isolation for exact and approximate polynomials using Descartes’ rule of signs (2010) Google Scholar
 Stroud, KA, Booth, DJ: Engineering Mathematics. Palgrave Macmillan, Basingstoke (2013) Google Scholar
 Salle, JL, Lefschetz, S: Stability by Liapunov’s Direct Methods with Applications. Elsevier, Amsterdam (1961) Google Scholar
 Wiggins, S: Introduction to Applied Nonlinear Dynamical Systems and Chaos, vol. 2, p. 110. Springer, Berlin (2003) MATHGoogle Scholar
 VargasDeLeón, C: On the global stability of SIS, SIR and SIRS epidemic models with standard incidence. Chaos Solitons Fractals 44(12), 11061110 (2011) MATHView ArticleGoogle Scholar
 Agency, CI: The CIA World Factbook 2012. Skyhorse Publishing, New York (2012) Google Scholar
 Tate, JE, Rheingans, RD, O’Reilly, CE, Obonyo, B, Burton, DC, Tornheim, JA, Adazu, K, Jaron, P, Ochieng, B, Kerin, T, Calhoun, L, Hamel, M, Laserson, K, Breiman, RF, Feikin, DR, Mintz, ED, Widdowson, MA: Rotavirus disease burden and impact and costeffectiveness of a rotavirus vaccination program in Kenya. J. Infect. Dis. 200, suppl. 1, S76S84 (2009) View ArticleGoogle Scholar
 Vesikari, T, Matson, DO, Dennehy, P, Van Damme, P, Santosham, M, Rodriguez, Z, Dallas, MJ, Heyse, JF, Goveia, MG, Black, SB, et al.: Safety and efficacy of a pentavalent humanbovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354, 2333 (2006) View ArticleGoogle Scholar
 Vesikari, T, Isolauri, E, D’Hondt, E, Delem, A, André, F, Zissis, G: Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 323(8384), 977981 (1984) View ArticleGoogle Scholar
 Glass, RI, Parashar, UD, Bresee, JS, Turcios, R, Fischer, TK, Widdowson, MA, Jiang, B, Gentsch, JR: Rotavirus vaccines: current prospects and future challenges. Lancet 368(9532), 323332 (2006) View ArticleGoogle Scholar
 Flores, J, Gonzalez, M, Perez, M, Cunto, W, PerezSchael, I, Garcia, D, Daoud, N, Chanock, R, Kapikian, A: Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 329(8538), 882884 (1987) View ArticleGoogle Scholar
 Wang, Y, Cao, J: Global dynamics of multigroup SEI animal disease models with indirect transmission. Chaos Solitons Fractals 69, 8189 (2014) View ArticleMathSciNetGoogle Scholar